Correlation Between Carbon Dioxide Measured in End of Exhalation and Arterial Blood

NCT ID: NCT01646008

Last Updated: 2015-12-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

32 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-04-30

Study Completion Date

2013-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to study the correlation between carbon dioxide measured by capnography at the enf of exhalation and arterial blood in COPD patients with nasal cannula in critical care unit.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Correlation Between Exhaled Carbon Dioxide and in Arterial Blood

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

respiratory

To measure carbon dioxide by capnography and arterial blood

Intervention Type OTHER

Three times per day will be measured exhaled carbon dioxide and obtained in arterial blood sample.

to measure carbon dioxide by capnography and arterial blood

Intervention Type OTHER

three times per day we will obtained arterial blood samples and measurements of carbon dioxide by capnography

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

To measure carbon dioxide by capnography and arterial blood

Three times per day will be measured exhaled carbon dioxide and obtained in arterial blood sample.

Intervention Type OTHER

to measure carbon dioxide by capnography and arterial blood

three times per day we will obtained arterial blood samples and measurements of carbon dioxide by capnography

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults
* COPD patients

Exclusion Criteria

* Under-aged
* Pregnant
* Major burns
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital Universitario Getafe

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Susana Arias Rivera

Registered Nurse

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Susana Arias-Rivera, Graduate

Role: PRINCIPAL_INVESTIGATOR

Hospital Universitario de Getafe, Spain

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Universitario de Getafe

Getafe, Madrid, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Carbon dioxide Getafe

Identifier Type: -

Identifier Source: org_study_id